Stroke was the fourth leading cause of death in the US last year, accounting for 162,600 deaths, according to preliminary data.

When it comes to weight loss, finding the right solution can feel like searching for a needle in a haystack. For many, Ozempic has emerged as a standout ...

Recent clinical studies have revealed groundbreaking developments in treating knee osteoarthritis through metabolic ...

But after starting a non-FDA approved GLP-1 agonist—an injectable drug similar to the diabetes drug Ozempic and the ...

Correspondent Jon Wertheim revisits 60 Minutes' coverage of former mobile giant Nokia and discusses potential risks for the ...

Bonnie Chapman attributed her weight loss to a Semaglutide drug called Tirzepatide - which is similar to the weight loss ...

Eli Lilly and Company disappointed with missed earnings, lower guidance. Click here for my review of LLY Q3 earnings and a ...

SHE may be just 39, but recent photos of Kelly Osbourne have left even ... in four months - Kelly has had to vehemently deny taking Ozempic. She told People Magazine: "I just have to clarify ...

For much of 2024, Novo Nordisk has been crediting Ozempic and Wegovy with the company's success. But just a couple ... Image source: Getty Images. Right now, GLP-1 agonists are primarily focused ...

For much of 2024, Novo Nordisk has been crediting Ozempic and Wegovy with the company's success. But just a couple of days ago, Novo quietly announced a major update regarding Rybelsus.